Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance Testing Utilizing AlloSure to Assess Rejection Following Transplantation and Personalization of Immunosuppressive Therapy

NCT05747053 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.

NCT NCT05747053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05747053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance Testing Utilizing AlloSure to Assess Rejection Following Transplantation and Personalization of Immunosuppressive Therapy
Lead sponsor
George Washington University
Phase
Observational
Overall status
Terminated
Start date
October 1, 2020
Completion date
December 8, 2022
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, chronic, kidney diseases, kidney failure, kidney failure, acute, kidney failure, chronic, kidney injury, kidney ischemia, kidney transplant infection, kidney transplant rejection, kidney transplant; complications